On March 16, the Endocrine Society conducted a “virtual” Research Hill Day where Endocrine Society members from across the U.S. met with their congressional representatives and their staff through Zoom, Skype, conference lines, and other electronic meeting platforms while the Capitol complex is closed for the pandemic and security reasons. During these meetings, Endocrine Society members urged Congress to provide an increase...
Obesity has been a crisis in the U.S. for decades and unfortunately it continues to impact millions of Americans. According to CDC data, approximately 42.4% of adults in the U.S. are obese, which has resulted in an estimated $147 billion in medical costs. There is also an alarming connection between obesity and COVID-19. People with obesity contracting COVID-19 are more likely to be hospitalized and placed in intensive care than those who are not obese. The...
As Congress and the Biden administration begin work on the upcoming year’s (FY 2022) budget and appropriations priorities, the Endocrine Society will continue to advocate for increased research funding. As in previous years, the Endocrine Society will advocate for increased funding for the National Institutes of Health (NIH) and other federal research funding agencies that...
On December 1, 2020, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician Fee Schedule (MPFS) final rule for CY 2021. This rule updates payment policies and payment rates for Part B services furnished under the MPFS, as well as makes changes to the Quality Payment Program. As a result of changes included...
It took weeks of intense, protracted negotiation, but just days before Christmas, House and Senate leaders finally clinched an agreement to send a massive end-of-year legislative package, including $900 billion in coronavirus relief, a $1.4 trillion spending bill to fund all federal agencies until the end of September 2021, and extension of the Special Diabetes...
As 2020 winds down, Endocrine News is taking a quick jaunt down memory lane to focus on the many accomplishments the Endocrine Society had over the course of the last 12 months. Despite various obstacles and upended plans, 2020 turned out to be a remarkable year for progress and successful new endeavors. We were somewhere...
The Endocrine Society is an advocate for transgender patients and ensuring their access to gender-affirming, evidence-based healthcare. During the Fall, the Society’s Transgender Special Interest Group and members of the Pediatric Endocrine Society formed a working group to update Society documents and develop new material on care for transgender individuals to be used in advocacy...
In the wake of Joe Biden’s win of the 2020 presidential election, the Endocrine Society has looked at what a change in presidential administration could mean for its policy agenda and provided a few predictions: Immediate Priorities The “lame duck” period and first 100 days of a Biden Administration will likely be dominated by urgent efforts...
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
In the wake of Joe Biden’s win of the 2020 presidential election, the Endocrine Society has looked at what a change in presidential administration could mean for its policy agenda and provided a few predictions: Immediate Priorities The “lame duck” period and first 100 days of a Biden Administration will likely be dominated by urgent efforts...
